MAM
Marquette Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-497
| Closed | -$117K | – | 203 |
|
|
2023
Q4 | $117K | Hold |
497
| – | – | 0.02% | 99 |
|
|
2023
Q3 | $97.4K | Hold |
497
| – | – | 0.02% | 104 |
|
|
2023
Q2 | $104K | Hold |
497
| – | – | 0.03% | 115 |
|
|
2023
Q1 | $100K | Hold |
497
| – | – | 0.03% | 110 |
|
|
2022
Q4 | $108K | Hold |
497
| – | – | 0.03% | 106 |
|
|
2022
Q3 | $98K | Hold |
497
| – | – | 0.03% | 106 |
|
|
2022
Q2 | $106K | Hold |
497
| – | – | 0.03% | 125 |
|
|
2022
Q1 | $141K | Hold |
497
| – | – | 0.03% | 119 |
|
|
2021
Q4 | $187K | Hold |
497
| – | – | 0.04% | 105 |
|
|
2021
Q3 | $205K | Hold |
497
| – | – | 0.05% | 94 |
|
|
2021
Q2 | $184K | Hold |
497
| – | – | 0.04% | 97 |
|
|
2021
Q1 | $144K | Hold |
497
| – | – | 0.03% | 110 |
|
|
2020
Q4 | $124K | Hold |
497
| – | – | 0.03% | 114 |
|
|
2020
Q3 | $113K | Hold |
497
| – | – | 0.03% | 98 |
|
|
2020
Q2 | $87K | Hold |
497
| – | – | 0.03% | 120 |
|
|
2020
Q1 | $63K | Hold |
497
| – | – | 0.03% | 138 |
|
|
2019
Q4 | $76K | Hold |
497
| – | – | 0.02% | 117 |
|
|
2019
Q3 | $66K | Hold |
497
| – | – | 0.02% | 131 |
|
|
2019
Q2 | $71K | Hold |
497
| – | – | 0.02% | 128 |
|
|
2019
Q1 | $72K | Buy |
+497
| New | +$72K | 0.02% | 125 |
|